| 
The following press releases are available in PDF format.
Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD (pdf)
HealthEdge™
Announces the Availability of HealthEdge Payor™
2.0 (pdf)
AngioScore Completes $30 Million Financing to Fund U.S. Product Launch (pdf)
Acuity Pharmaceuticals Enters Agreement with ZaBeCor (pdf)
ESTECH Launches COBRA Adhere XL Cardiac Ablation Product (pdf)
ESTECH Launches COBRA Adhere XL Cardiac Ablation Product
(pdf)
Valera Pharma Sets IPO At 3.75 Million Shares, $10-$12 A Share (pdf)
Acuity Completes Patient Enrollment in Phase II Trail (pdf)
Health Hero Network Launches Medicare Project (pdf)
CareGuide and Patient Infosystems Complete Merger (pdf)
ESTECH Announces Cobra® Adhere™ Radio Frequency Ablation Device Receives First Ever CE
Indication for Surgical Treatment of Atrial Fibrillation (AF) (pdf)
Tufts-New England Medical Center Study Shows Reduced Hospitalizations and Bed Days of Care with Health Buddy®
System (pdf)
Navitas Cancer Rehabilition Centers
added to Psilos Portfolio (pdf)
AngioScore Names Medical Device Industry Veteran
Thomas R. Trotter Chief Executive Officer
Aetna to Acquire ActiveHealth Management
UnitedHealth Group Announces Acquisition of Definity Health
Spheris Announces Acquisition of Avicis, formerly known
as HealthScribe
Navitas Cancer Rehabilition Centers added to Psilos Portfolio
CareGuide Merges with Patient Infosystems
AngioScore Receives FDA Clearance
|
